LA
AGN

Lee Ainslie’s Allergan plc AGN Stock Holding History

Lee Ainslie’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,605
Closed -$1.7M – 722
2020
Q1 		$1.7M Sell
9,605
-12,836
-57% -$2.42M 0.04% 209
2019
Q4 		$4.29M Sell
22,441
-6,205
-22% -$1.12M 0.06% 173
2019
Q3 		$4.82M Sell
28,646
-10,164
-26% -$1.66M 0.07% 155
2019
Q2 		$6.5M Sell
38,810
-11,400
-23% -$1.58M 0.09% 95
2019
Q1 		$7.35M Buy
+50,210
New +$7.28M 0.1% 113
2016
Q3 		– Sell
-878,319
Closed -$203M – 161
2016
Q2 		$203M Sell
878,319
-532,043
-38% -$123M 2.75% 17
2016
Q1 		$378M Buy
1,410,362
+730,432
+107% +$209M 5.98% 3
2015
Q4 		$212M Buy
679,930
+99,512
+17% +$29.6M 3.06% 13
2015
Q3 		$158M Sell
580,418
-879,142
-60% -$270M 2.7% 17
2015
Q2 		$443M Buy
1,459,560
+1,143,372
+362% +$341M 6.76% 2
2015
Q1 		$94.1M Buy
+316,188
New +$90.1M 1.51% 27

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Lee Ainslie's AGN Position: Q2 2020 in Review

Lee Ainslie sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,605 shares — an estimated $1.7M sold.

Lee Ainslie first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $443M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Lee Ainslie reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Lee Ainslie sold 9,605 Allergan plc shares in Q2 2020, an estimated $1.7M.
  • Lee Ainslie first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • Lee Ainslie's Allergan plc position peaked at $443M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Maverick Capital's 13F filing for Q2 2020, filed 14 Aug 2020.